Vigabatrin - Targeon SASAlternative Names: Vigabatrin soluble tablet formulation - Targeon SAS
Latest Information Update: 25 Aug 2014
At a glance
- Originator Targeon
- Class Aminobutyric acids; Antiepileptic drugs; Small molecules
- Mechanism of Action 4-aminobutyrate transaminase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Epilepsy; Infantile spasms
Most Recent Events
- 01 May 2014 Clinical trials in Infantile spasms (In children, In infants) in France (PO)
- 01 May 2014 Clinical trials in Epilepsy (In children, In infants) in France (PO)